Distinct Genomic Associations to Predict Acute Myeloid Leukemia (AML) Progression from Myelodysplastic Syndromes (MDS)

被引：0
|
作者：
Madanat, Yazan F. [1 ]
Sekeres, Mikkael A. [1 ]
Mukherjee, Sudipto [1 ]
Al-Issa, Karam [1 ]
Hirsch, Cassandra M. [2 ]
Gerds, Aaron T. [1 ]
Jha, Babal K. [2 ]
Adema, Vera [2 ]
Advani, Anjali [1 ]
Nagata, Yasunobu [2 ]
Kuzmanovic, Teodora [2 ]
Carraway, Hetty E. [1 ]
Przychodzen, Bartlomiej [2 ]
Maciejewski, Jaroslaw P. [2 ]
Nazha, Aziz [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA
[2] Cleveland Clin, Translat Hematol & Oncol, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
MDS; genomics; molecular; leukemia; NGS;
D O I：
10.1016/j.clml.2018.07.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-161
引用
收藏
页码：S261 / S261
页数：1
相关论文
共 50 条
  • [31] ACUTE MYELOID LEUKEMIA PROGRESSION IN MYELODYSPLASTIC SYNDROMES, RESULTS FROM THE ARGENTINE REGISTRY
    Enrico, A.
    Kornblihtt, L.
    Milone, J.
    Arbelbide, J.
    Fantl, D.
    Alfonso, G.
    Iastrebner, M.
    Flores, M.
    Correa, W.
    Negri Aranguren, P.
    Celebrin, L.
    Agra, M.
    Watman, N.
    Basquiera, A.
    Bestach, Y.
    Bengio, R.
    Larripa, I.
    Bell, C.
    HAEMATOLOGICA, 2014, 99 : 616 - 617
  • [32] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [33] Distinction of Early and Late Molecular Events In Patients with Myelodysplastic Syndromes (MDS) Who Progressed to Acute Myeloid Leukemia (AML)
    Afable, Manuel G., II
    Makishima, Hideki
    Sakaguchi, Hirotoshi
    Jerez, Andres
    Jankowska, Anna Malgorzata
    Guinta, Kathryn M.
    Abu Kar, Sara
    Traina, Fabiola
    Sugimoto, Yuka
    O'Keefe, Christine
    Tiu, Ramon V.
    Sekers, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2011, 118 (21) : 1522 - 1523
  • [34] A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML)
    Navada, S. C.
    Garcia-Manero, G.
    Hearn, K.
    Odchimar-Reissig, R.
    Demakos, E.
    Alvarado, Y.
    Daver, N.
    DiNardo, C.
    Konopleva, M.
    Borthakur, G.
    Azarnia, N.
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2015, 39 : S45 - S45
  • [35] Phase II study of Mylotarg plus Troxatyl in patients with refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
    Giles, FJ
    Garcia-Manero, G
    O'Brien, S
    Estey, E
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 212B - 212B
  • [36] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    David P. Steensma
    Medrdad Abedi
    Rafael Bejar
    Christopher R. Cogle
    Kathryn Foucar
    Guillermo Garcia-Manero
    Tracy I. George
    David Grinblatt
    Rami Komrokji
    Xiaomei Ma
    Jaroslaw Maciejewski
    Daniel A. Pollyea
    Michael R. Savona
    Bart Scott
    Mikkael A. Sekeres
    Michael A. Thompson
    Arlene S. Swern
    Melissa Nifenecker
    Mary M. Sugrue
    Harry Erba
    BMC Cancer, 16
  • [37] Karyotype evolution and AML progression in 163 myelodysplastic syndromes (MDS)
    Bernasconi, F.
    Boni, M.
    Cavigliano, P. M.
    Giardini, I
    Zappatore, R.
    Calabroni, S.
    Rocca, B.
    Dambruoso, I
    Caresana, M.
    Astori, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 158 - 158
  • [38] Outcome of Patients (pts) with Acute Myeloid Leukemia (AML) Evolving From Myelodysplastic Syndromes (MDS) Post Hypomethyling Agents (HMA) Failure
    Ghanem, Hady
    Kantarjian, Hagop M.
    Manero, Guillermo Garcia
    Ravandi, Farhad
    Cortes, Jorge E.
    Takahashi, Koichi
    O'BrienMd, Susan M.
    Pierce, Sherry A.
    Kadia, Tapan M.
    Jabbour, Elias J.
    BLOOD, 2012, 120 (21)
  • [39] Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
    Steensma, David P.
    Abedi, Medrdad
    Bejar, Rafael
    Cogle, Christopher R.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    George, Tracy I.
    Grinblatt, David
    Komrokji, Rami
    Ma, Xiaomei
    Maciejewski, Jaroslaw
    Pollyea, Daniel A.
    Savona, Michael R.
    Scott, Bart
    Sekeres, Mikkael A.
    Thompson, Michael A.
    Swern, Arlene S.
    Nifenecker, Melissa
    Sugrue, Mary M.
    Erba, Harry
    BMC CANCER, 2016, 16
  • [40] PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Przychodzen, Bartlomiej P.
    Gu, Xiaorong
    You, Dewen
    Hirsch, Cassandra M.
    Clemente, Michael J.
    Sekeres, Mikkael A.
    Nazha, Aziz
    Makishima, Hideki
    Maciejewski, Jaroslaw P.
    BLOOD, 2016, 128 (22)
12345